Riverwater Partners’s Abeona Therapeutics ABEO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$128K Hold
24,304
– – 0.04% 206
2026
Q2
$150K Buy
24,304
+5,238
+27% +$28.8K 0.04% 208
2026
Q1
$85.4K Sell
19,066
-309
-2% -$1.54K 0.03% 211
2025
Q4
$102K Buy
19,375
+3,518
+22% +$17.7K 0.04% 209
2025
Q3
$83.7K Buy
15,857
+4,963
+46% +$31.5K 0.03% 215
2025
Q2
$61.9K Buy
+10,894
New +$62K 0.03% 201

Other funds holding ABEO

Riverwater Partners's ABEO Position: Q3 2026 in Review

Riverwater Partners held its Abeona Therapeutics (ABEO) position steady in Q3 2026 at 24,304 shares worth $128K. The position accounts for 0.04% of the portfolio, ranked #206.

Riverwater Partners first reported a position in ABEO in Q2 2025 and has held it in 6 quarters since. The position peaked at $150K in Q2 2026. 116 funds tracked by Wall St. Rank hold ABEO as of Q3 2026.

  • Riverwater Partners held 24,304 shares of Abeona Therapeutics worth $128K as of Q3 2026.
  • Riverwater Partners left its Abeona Therapeutics share count unchanged in Q3 2026.
  • Abeona Therapeutics made up 0.04% of Riverwater Partners's portfolio in Q3 2026, its #206 holding.
  • Riverwater Partners first reported a position in Abeona Therapeutics in Q2 2025 and has held it in 6 quarters since.
  • Riverwater Partners's Abeona Therapeutics position peaked at $150K in Q2 2026.
  • 116 funds tracked by Wall St. Rank held Abeona Therapeutics as of Q3 2026.

Based on Riverwater Partners's 13F filing for Q3 2026, filed 3 Nov 2026.